Krsnaa Diagnostics Board Approves Comprehensive Leadership Restructuring
Krsnaa Diagnostics has undertaken major governance restructuring through its April 17, 2026 board meeting, appointing Mr. Raju Venkatraman and Ms. Lilian Jessie Paul as independent directors while formalizing Chandra Prakash Singh as Interim CFO. The company has reconstituted all five key committees with new leadership structure effective April 25, 2026, ensuring enhanced oversight and governance capabilities during the leadership transition period.
*this image is generated using AI for illustrative purposes only.
Krsnaa Diagnostics has announced comprehensive leadership changes following its board meeting held on April 17, 2026. The diagnostic services company has approved significant appointments and restructuring measures as part of strengthening its governance framework.
New Director Appointments
The board has approved the appointment of two new independent directors and re-appointment of one existing director, subject to member approval through postal ballot. These strategic appointments bring enhanced expertise to the company's leadership structure.
| Director Appointments: | Position | Term |
|---|---|---|
| Mr. Raju Venkatraman: | Additional Director (Independent) | April 25, 2026 to April 24, 2028 |
| Ms. Lilian Jessie Paul: | Additional Director (Independent) | April 25, 2026 to April 24, 2028 |
| Mr. Chetan Desai: | Re-appointed as Independent Director | April 25, 2026 to April 24, 2031 |
Mr. Raju Venkatraman brings extensive experience as a serial entrepreneur in diagnostics, healthcare, and IT sectors. He is the founder and former Chairman of Medall Healthcare Private Limited. Ms. Lilian Jessie Paul contributes over 25 years of marketing and corporate strategy expertise, currently serving on boards of PB Fintech and CreditAccess Grameen.
CFO Appointment and Leadership Transitions
The company has formalized the appointment of Chandra Prakash Singh as Interim Chief Financial Officer, designated as Key Managerial Personnel effective April 17, 2026. Singh will discharge CFO duties until a permanent appointment is made.
| Leadership Changes: | Effective Date | Status |
|---|---|---|
| Chandra Prakash Singh: | April 17, 2026 | Interim CFO Appointment |
| Ms. Pallavi Bhatevara: | April 25, 2026 | Tenure Completion |
| Mr. Rajiva Ranjan Verma: | April 24, 2026 | Tenure Completion |
| Ms. Chhaya Palrecha: | April 24, 2026 | Tenure Completion |
Singh brings over 28 years of finance experience across pharmaceuticals, FMCG, real estate, and consultancy sectors. He previously served as CFO at Brinton Pharmaceuticals Limited and holds qualifications as a Cost Accountant with CFO Program completion from IIM Calcutta.
Comprehensive Committee Restructuring
Following the director appointments, the board has approved comprehensive committee restructuring effective April 25, 2026. The reconstituted committees ensure enhanced governance and oversight capabilities across all key areas.
| Committee: | Chairperson | Total Members |
|---|---|---|
| Audit Committee: | Mr. Chetan Desai | 6 members |
| Nomination & Remuneration: | Mr. Raju Venkatraman | 4 members |
| Corporate Social Responsibility: | Mr. Rajendra Mutha | 4 members |
| Stakeholders Relationship: | Mr. Adesh Kumar Gupta | 3 members |
| Risk Management: | Mr. Raju Venkatraman | 4 members |
The board meeting, which commenced at 12:00 hours and concluded at 15:50 hours, demonstrates the company's commitment to strengthening its governance framework while ensuring continuity in operations during leadership transitions. The board has placed on record its appreciation for the valuable contributions of directors completing their tenure.
Historical Stock Returns for Krsnaa Diagnostics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.07% | +2.91% | +4.15% | -22.56% | -24.37% | -37.99% |
What strategic initiatives might Krsnaa Diagnostics pursue under the new leadership team's guidance, particularly given Mr. Venkatraman's background in healthcare entrepreneurship?
How will the search for a permanent CFO impact Krsnaa's financial reporting timeline and potential expansion plans in the diagnostic services sector?
Could these leadership changes signal preparation for major corporate actions such as acquisitions, IPO considerations, or strategic partnerships in the healthcare industry?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
